Expression of thymidine phosphorylase in human cervical cancer

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 709-716

  Hata, Kohkichi ^a   Takebayashi, Yuji ^b   Iida, Kohji ^a   Fujiwaki, Ritsuto ^a   Fukumoto, Manabu ^c   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Expression; Immunohistochemistry; Microvessel density; Thymidine phosphorylase

Indexed keywords

THYMIDINE PHOSPHORYLASE; VON WILLEBRAND FACTOR;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; THYMIDINE PHOSPHORYLASE; UTERINE CERVICAL NEOPLASMS;

EID: 0032896576     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Folkman J, Watson K, and Ingber D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61, 1989.
2. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
3. Bicknell R, Harris AL: Novel growth regulatory factors and tumour angiogenesis. Eur J Cancer 27: 781-785, 1991.
4. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y, Akiyama S: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biocem 114: 9-14, 1993.
5. Miyadera K, Dohmae N, Sumizawa T, Haraguchi M, Furukawa T, Yamada Y, Akiyama S: Structural characterization of thymidine phosphorylase purified from human placenta. Biochem Biophys Res Commun 212: 1040-1045, 1995.
6. Morris PB, Ellis MN, Swain JL: Angiogenic potency of nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol 21: 351-358, 1989.
7. Moghaddam A, Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31: 12141-12146, 1992.
8. Haraguchi M, Kazutaka M, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y: Angiogenic activity of enzymes. Nature 368: 198, 1994.
9. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Ricknell R, Gatter KC, Harris AL: The antigenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275-280, 1996.
10. Maeda K, Chung Y-S, Ogawa S, Takatsuka S, Kang S-M, Sawada T, Onoda N, Kato Y, Sowa M: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888, 1996.
11. Takehayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T, Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996.
12. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.
13. O'Brein TS, Fox SB, Dickison AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, Bicknell R, Harris AL: Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56: 4799-4804, 1994.
14. Wiggins DL, Granai CO, Steinhoff MM Calabresi P: Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 56: 353-356, 1995.
15. Bremer GL, Tiebosch ATMG, van der Putten HWHM, Scheuten HJA, de Haan J, Arends J-W: Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol 174: 126-131, 1996.
16. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
17. Creasman WT, Fetter BF, Clarke-Pearson DL, Kaufmann L, Parker RT: Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 153: 164-172, 1985.
18. Nishida M, Hino A, Mori K, Matsumoto T, Tanaka Y, Ishitsuka H: Cloning of hybridomas producing anti-human thymidine phosphorylase (dThdPase) and establishment ELISA for measuring dThdPase. J Jpn Soc Cancer Ther 29: 1192, 1994.
19. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL: Platelet-derived endothelial cell growth factor/ thymidine phosphorylase expression in normal tissue: an immunohistochemical study. J Pathol 179: 180-190, 1995.
20. Weidner N, Carrol PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
21. Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
22. Mantel N, Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1996.
23. Cox DR: Regression models and life tables. JR Stat Soc B 31: 1333-1335, 1972.
24. Pauly JL, Paolini NS, Ebarb RL, Germain MJ: Elevated thymidine phosphorylase activity in the plasma and ascitic fluids of tumor-bearing animals. Proc Soc Exp Biol Med 157: 262-267, 1978.
25. Takebayashi Y, Yamada K, Miyadera K, Kinoshita F, Aiko D, Okuyama H, Yamada Y, Akiyama S, Aikou T: The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 32: 1227-1232, 1996.
26. Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, Yoshinouchi M, Okuda H, Kudo T: Different angiogenic pathway in human cervical cancers. Gynecol Oncol 68: 38-44, 1998.
27. Kamura T, Tsukamoto M, Tsuruchi N, Saito T, Matsuyama T, Akazawa K, Nakano H: Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 69: 181-186, 1992.
28. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y Ishitsuka H: Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharma Bull 31: 175-178, 1983.
29. Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Stratford IJ, Harris AL: Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675, 1996.
30. Kumagai K, Yasui A, Nishida Y, Masuo K, Yoshitoshi A: The significance of preoperative chemotherapy for early gastric carcinoma. Surgery Today 23: 875-879, 1993.
31. Koizumi W, Kurihara M, Sasai T, Yoshida S, Morise K, Imamura A, Akazawa S, Betsuyaku T, Ohkuho S, Takahashi H, Akiya T, Hamada T, Kiyohashi A: A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci. Cancer 72: 658-662, 1993.